Skip to main content
. 2017 Jan 25;7:41309. doi: 10.1038/srep41309

Figure 4. Distribution of the cell cycle phases after trastuzumab treatment.

Figure 4

The percentage of cells in G1, S, and G2 phases was evaluated in BT474 wt and BT474r cells, with or without miR-30b overexpression, and with or without trastuzumab treatment.